Delivery Order SPE2DB25D3404-SPE2DB25FUNHQ

Award Date 5/7/25
Potential Completion Date 5/8/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $1,515.84 and has an ultimate completion date of March 25, 2025. The contract is for the delivery of KENALOG-40 200 MG/5 ML VIAL 5ML, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,339.04, is for the delivery of KENALOG-40 200 MG/5 ML VIAL 5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 8, 2025. The contract does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,466.08, is for the delivery of 4568039003 KENALOG-40 200 MG/5 ML VIAL 5ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside arrangement with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,757.06, is for the delivery of KENALOG-40 200 MG/5 ML VIAL 5ML, a medication used for various medical conditions. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 4, 2025. This award is not designated with a set-aside....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of KENALOG-40 200 MG/5 ML VIAL 5ML, a pharmaceutical product. The contract has a ceiling value of $1,778.40 and is a firm fixed price contract. It is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,779.34 firm fixed-price contract is for the delivery of KENALOG-40 400 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $2,114.77, is for the delivery of KENALOG-40 200 MG/5 ML VIAL 5ML, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,480.35, is a delivery order for the pharmaceutical product KENALOG-40 400 MG/10 ML VIAL 10ML. The contract has an ultimate completion date of January 6, 2025 and is a firm fixed-price contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999 through December 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that supplies a wide range of medications and medical supplies to federal agencies and healthcare programs. The specific delivery order is for KENALOG-40 40 MG/ML vials, with a ceiling value of $1,057.92 and a completion...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of KENALOG-40 200 MG/5 ML VIAL 5ML medical products. The $1,321.20 firm fixed price delivery order has a completion date of November 29, 2023 and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUNHQ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KENALOG-40 200 MG/5 ML VIAL 5ML. The contract has a firm fixed price of $2,368.29 and a completion date of May 8, 2025. It is not a set-aside contract, indicating open competition.

The contract is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen Drug Corp and the DLA Troop Support Medical, valued at $999,999,999.00. This IDC, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. Through this IDC, AmerisourceBergen Drug Corp supplies a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/6/25, 9:54 AM